Watch ABBV. Know when insiders buy.
One email the day a filing lands. Free.
ABBV
AbbVie Inc.
284.80
−4.28 −1.48%
USD · close Oct 21
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
34
FLAG · shorts 34
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 1
buys / sells · latest disclosed Sep 18
Big money
3 / 15
tracked funds hold it
Calls on record
0
nobody we score has called it yet
MKT CAP $503.3BP/E 80.5DIV YIELD 2.40%FCF YIELD 3.62%REV TTM $64.4B +10.4%NET INCOME $6.3B +67.7%NET DEBT $57.9B52W 197.38 – 289.08SEC XBRL · TTM TO Invalid Date
Dividends
$6.83
Per share, trailing 12 months
2.40%
Yield at 284.80
276%
Payout, last fiscal year
$980M
Buybacks, last fiscal year
| Quarter | Declared per share | Dividends paid | Buybacks |
|---|---|---|---|
| Q2 2026 · Jun 30 | $1.73 | $3.1B | $9M |
| Q1 2026 · Mar 31 | $1.73 | $3.1B | $1.5B |
| Q4 2025 · Dec 31 | $1.73 | $2.9B | $3M |
| Q3 2025 · Sep 30 | $1.64 | $2.9B | $4M |
| Q2 2025 · Jun 30 | $1.64 | $2.9B | $12M |
| Q1 2025 · Mar 31 | $1.64 | $2.9B | $961M |
| Q4 2024 · Dec 31 | $1.64 | $2.8B | $358M |
| Q3 2024 · Sep 30 | $1.55 | $2.8B | $17M |
| Q2 2024 · Jun 30 | $1.55 | $2.8B | $9M |
| Q1 2024 · Mar 31 | $1.55 | $2.8B | $1.3B |
| Q4 2023 · Dec 31 | $1.55 | $2.6B | $3M |
| Q3 2023 · Sep 30 | $1.48 | $2.6B | $4M |
Dividends declared per share as tagged in the filings. Ex-dates and pay dates aren't in XBRL; check the company's investor site for the calendar.